Top 10 Balance Capital Partners L P Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PRM | PERIMETER SOLUTIONS INC | 70% | 2.74M | $97.5M | +0.00%(+0) | $25.04(+35.36%) | 2026-06-30 | |
| XBI | SPDR SERIES TRUST | 7.27% | 64.0K | $10.1M | new | $138.51(+13.64%) | 2026-06-30 | |
| RHLD | RESOLUTE HLDGS MGMT INC | 6.69% | 64.5K | $9.3M | +0.00%(+0) | $139.29(-4.19%) | 2026-06-30 | |
| TSM | TAIWAN SEMICONDUCTOR MANUFAC | 3.77% | 11.0K | $5.3M | new | $397.04(+7.38%) | 2026-06-30 | |
| BLTE | BELITE BIO INC | 2.49% | 22.5K | $3.5M | +55.17%(+8.00K) | $156.81(+3.82%) | 2026-06-30 | |
| CPNG | COUPANG INC | 2.45% | 196.9K | $3.4M | new | $17.82(-9.51%) | 2026-06-30 | |
| SN | SHARKNINJA INC | 2.24% | 20.5K | $3.1M | new | $124.95(+48.15%) | 2026-06-30 | |
| MRVL | MARVELL TECHNOLOGY INC | 1.92% | 9.0K | $2.7M | new | $192.85(+15.13%) | 2026-06-30 | |
| TTMI | TTM TECHNOLOGIES INC | 1.75% | 13.0K | $2.4M | new | $137.66(+1.70%) | 2026-06-30 | |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 1.42% | 199.0K | $2.0M | new | $7.69(-11.76%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (2 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +14.73% |
| Top 20 Holdings Unweighted | — | — | — | — | -4.72% |
Balance Capital Partners L P reports $139.32M in US-listed equity holdings across 10 positions in its most recent 13F filing. Its largest disclosed positions are PRM (70.0%), XBI (7.3%) and RHLD (6.7%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +14.73% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Balance Capital Partners L P, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Balance Capital Partners L P’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2109256). View Balance Capital Partners L P’s 13F filings on SEC